Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastasis of unknown origin.

J E Perchalski1, K L Hall, M A Dewar

  • 1Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville.

Primary Care
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A descriptive evaluation with follow-up of the clinical significance of atypical immature squamous metaplasia of the cervix.

Journal of lower genital tract disease·2015
Same author

A randomized-clinical trial examining a neoprene abdominal binder in gynecologic surgery patients.

Clinical and experimental obstetrics & gynecology·2015
Same author

Cation regulation in Anacystis nidulans.

Planta·2014
Same author

Chloride transport in Anacystis nidulans.

Planta·2014
Same author

40-Gbitys cascadable all-optical logic with an ultrafast nonlinear interferometer.

Optics letters·2009
Same author

50-Gbit / s optical pulse storage ring using novel rational-harmonic modulation.

Optics letters·2009

A structured approach to evaluating patients with metastasis of unknown origin (MUO) aids in identifying treatable tumors or palliation needs. Early biopsy and multidisciplinary communication are crucial for diagnosis and patient care.

Area of Science:

  • Oncology
  • Pathology
  • Internal Medicine

Background:

  • Metastasis of unknown origin (MUO) presents diagnostic and therapeutic challenges.
  • Effective management requires a structured, symptom-directed evaluation.
  • Multidisciplinary communication is vital for optimal patient outcomes.

Purpose of the Study:

  • To outline a structured diagnostic approach for patients with MUO.
  • To emphasize early pathological examination and targeted investigations.
  • To guide treatment decisions balancing efficacy with patient quality of life.

Main Methods:

  • Symptom-directed physical examinations including thyroid, breast, pelvic, and rectal exams.
  • Initial laboratory analyses: CBC, urinalysis, serum calcium, liver function, fecal occult blood.

Related Experiment Videos

  • Sex-specific assays (PSA, HCG, AFP) and imaging (mammography, pelvic ultrasound, chest radiograph, abdominal CT) based on clinical suspicion.
  • Early biopsy of malignant tissue for comprehensive histopathology, immunohistochemistry, and electron microscopy.

    • Main Results:

    • A systematic evaluation can expedite the identification of treatable primary tumors or the need for palliative care.
    • Biopsy analysis, including receptor studies for female patients, is key to determining origin.
    • Limited further radiologic studies are recommended in the absence of specific symptoms.

    Conclusions:

    • A coordinated, pathology-oriented evaluation strategy improves diagnostic yield in MUO.
    • Treatment decisions should prioritize patient's functional status and likelihood of response.
    • Continuous support and focus on quality of life are paramount, regardless of diagnostic certainty.